NASDAQ: IARTIntegra Lifesciences Holdings Revenue
Integra Lifesciences Holdings revenue was $1.64B for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2025) ending on Sep 30, 2025 was $402.1M, down 3.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, IART annual revenue was $1.6B, with 4.5% growth year-over-year.
IART past revenue growth
How has IART's revenue growth performed historically?
Company
4.99%
Industry
11.05%
Market
21.98%
IART's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
IART's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
IART's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance
IART revenue history
Current Revenue
$1.6B
Current Earnings
-$495.3M
Current Profit Margin
-30.1%
Be the first to know when IART announces revenue.
IART Revenue History By Year
| IART Yearly Revenue | IART Revenue | IART Change | IART Revenue Growth |
|---|---|---|---|
| 2024-12-31 | $1.61B | $68.95M | +4.47% |
| 2023-12-31 | $1.54B | -$16.09M | -1.03% |
| 2022-12-31 | $1.56B | $15.22M | +0.99% |
| 2021-12-31 | $1.54B | $170.58M | +12.43% |
| 2020-12-31 | $1.37B | -$145.69M | -9.60% |
| 2019-12-31 | $1.52B | $45.12M | +3.06% |
| 2018-12-31 | $1.47B | $284.21M | +23.92% |
| 2017-12-31 | $1.19B | $196.16M | +19.77% |
| 2016-12-31 | $992.08M | $109.34M | +12.39% |
| 2015-12-31 | $882.73M | $86.02M | +10.80% |
| 2014-12-31 | $796.72M | $99.89M | +14.33% |
| 2013-12-31 | $696.83M | -$134.04M | -16.13% |
| 2012-12-31 | $830.87M | $50.79M | +6.51% |
| 2011-12-31 | $780.08M | $48.01M | +6.56% |
| 2010-12-31 | $732.07M | $49.58M | +7.26% |
| 2009-12-31 | $682.49M | $27.88M | +4.26% |
| 2008-12-31 | $654.60M | $104.15M | +18.92% |
| 2007-12-31 | $550.46M | $131.16M | +31.28% |
| 2006-12-31 | $419.30M | $141.36M | +50.86% |
| 2005-12-31 | $277.94M | $48.11M | +20.93% |
| 2004-12-31 | $229.83M | $44.23M | +23.83% |
| 2003-12-31 | $185.60M | $67.78M | +57.52% |
| 2002-12-31 | $117.82M | $24.38M | +26.09% |
| 2001-12-31 | $93.44M | $21.79M | +30.42% |
| 2000-12-31 | $71.65M | $28.77M | +67.11% |
| 1999-12-31 | $42.88M | $25.32M | +144.15% |
| 1998-12-31 | $17.56M | $2.82M | +19.09% |
| 1997-12-31 | $14.75M | $1.60M | +12.15% |
| 1996-12-31 | $13.15M | $2.92M | +28.54% |
| 1995-12-31 | $10.23M | $1.57M | +18.10% |
| 1994-12-31 | $8.66M | N/A | N/A |
Integra Lifesciences Holdings Revenue FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.